Ewing sarcoma

Karakolevska Ilova, Marija (2012) Ewing sarcoma. In: Soft Tissue, Bone, and Skin Malignancies, 02-08.12.2012, Salzburg,Austria. (Unpublished)

[img] Slideshow
Ewing sarcoma - case report.mk.ppt

Download (1336Kb)


Patients with metastases and recurrent disease still fare poorly, with 5-year survival rates of 20% witch highlights the need for novel chemotherapeutic agents, bisphosphonates and targeted therapy.Ewing's sarcoma has a propensity to metastasize to the lung, bone and bone marrow. This tumor can also involve the CNS with a relatively low incidence – 1-8%. Prognostic factors that confer poorer outcome are: serum LDH level, axial localization or older age ( > 15 years), size and volume, incomplete or no surgery for local therapy and time of relaps ( < 24 months ). This is a case report that brings out all of bad prognostic factors associated with disease free survivel and overoll survival.

Item Type: Conference or Workshop Item (Speech)
Subjects: Medical and Health Sciences > Clinical medicine
Divisions: Faculty of Medical Science
Depositing User: Marija Karakolevska
Date Deposited: 10 Dec 2012 16:32
Last Modified: 10 Dec 2012 16:32
URI: http://eprints.ugd.edu.mk/id/eprint/3284

Actions (login required)

View Item View Item